{"transactions":[{"id":827727,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2026-03-26T20:13:52.000Z","date":"2026-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":537,"price":92.23,"value":49527.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 11,160 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14882,"source":{"system":"sec-edgar","filing":"0002015975-26-000006","document":"wk-form4_1774556029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000201597526000006/wk-form4_1774556029.xml","form_type":"4"}},{"id":934719,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-21T21:05:28.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":8542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 16, 2026, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2026 and the remainder vesting monthly over three years."}],"balance_after":8542,"derivative":{"exercise_price":106.21,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":8542},"source":{"system":"sec-edgar","filing":"0002015975-26-000002","document":"wk-form4_1769029513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000201597526000002/wk-form4_1769029513.xml","form_type":"4"}},{"id":1085948,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T20:03:41.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":11841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":11841,"derivative":{"exercise_price":68.25,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":11841},"source":{"system":"sec-edgar","filing":"0000879169-25-000089","document":"wk-form4_1752782616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000089/wk-form4_1752782616.xml","form_type":"4"}},{"id":1085947,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Performance Shares","published_at":"2025-07-17T20:03:41.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":13154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."}],"balance_after":13154,"derivative":{"expiration_date":"2028-07-15","underlying":"Common Stock","underlying_shares":13154},"source":{"system":"sec-edgar","filing":"0000879169-25-000089","document":"wk-form4_1752782616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000089/wk-form4_1752782616.xml","form_type":"4"}},{"id":1085946,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2025-07-17T20:03:41.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":5261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Including the July 15, 2025 grant, this includes an aggregate of 13,117 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":15016,"source":{"system":"sec-edgar","filing":"0000879169-25-000089","document":"wk-form4_1752782616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000089/wk-form4_1752782616.xml","form_type":"4"}},{"id":1085945,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2025-07-17T20:03:41.000Z","date":"2025-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":182,"price":68.25,"value":12421.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0000879169-25-000089","document":"wk-form4_1752782616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000089/wk-form4_1752782616.xml","form_type":"4"}},{"id":1190203,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2025-03-27T21:05:11.000Z","date":"2025-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":537,"price":62.08,"value":33336.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 8,517 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":9937,"source":{"system":"sec-edgar","filing":"0001628280-25-015196","document":"wk-form4_1743109504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025015196/wk-form4_1743109504.xml","form_type":"4"}},{"id":1298261,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-22T21:06:26.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":5371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years."}],"balance_after":5371,"derivative":{"exercise_price":71.93,"expiration_date":"2035-01-16","underlying":"Common Stock","underlying_shares":5371},"source":{"system":"sec-edgar","filing":"0000879169-25-000033","document":"wk-form4_1737579977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000033/wk-form4_1737579977.xml","form_type":"4"}},{"id":1453156,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-07-17T16:28:41.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":5921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":5921,"derivative":{"exercise_price":64.25,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5921},"source":{"system":"sec-edgar","filing":"0000879169-24-000135","document":"wk-form4_1721233714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000135/wk-form4_1721233714.xml","form_type":"4"}},{"id":1453155,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2024-07-17T16:28:41.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":2646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the July 15, 2024 grant, this includes an aggregate of 10,474 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":10474,"source":{"system":"sec-edgar","filing":"0000879169-24-000135","document":"wk-form4_1721233714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000135/wk-form4_1721233714.xml","form_type":"4"}},{"id":1559972,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-27T17:04:32.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":21868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The March 25, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":21868,"derivative":{"exercise_price":57.48,"expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":21868},"source":{"system":"sec-edgar","filing":"0000879169-24-000066","document":"wk-form4_1711559063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000066/wk-form4_1711559063.xml","form_type":"4"}},{"id":1559971,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":55917,"kind":"person","name":"Trotta Matteo","position":1,"cik":"0002015975","reported_name":"Trotta Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM, Dermatology US"}}],"security":"Common Stock","published_at":"2024-03-27T17:04:32.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":7828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the March 25, 2024 RSU Grant, this includes an aggregate of 7,828 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7828,"source":{"system":"sec-edgar","filing":"0000879169-24-000066","document":"wk-form4_1711559063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000066/wk-form4_1711559063.xml","form_type":"4"}}]}